News

Amph, Iron Sucrose and FDA

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated New Drug Application (ANDA) for Iron Sucrose Injection, USP 50mg/2.5mL, 100mg/5mL,
Amphastar raised to Buy at Needham on iron sucrose injection approval
Amphastar Pharmaceuticals (NASDAQ:AMPH) has been upgraded to Buy from Hold at Needham after getting FDA approval for its generic iron sucrose injection to treat anemia associated with chronic kidney disease.
Amphastar announced FDA approval of iron sucrose injection
Pharmaceuticals announced yesterday morning that the Food and Drug Administration approved the company’s abbreviated new drug
Viatris receives US FDA approval for generic iron sucrose injection to treat IDA in chronic kidney disease
Viatris receives US FDA approval for generic iron sucrose injection to treat IDA in chronic kidney disease: Pittsburgh Tuesday, August 12, 2025, 18:00 Hrs [IST] Viatris Inc., a gl
FDA Approves First Generic Version of Venofer Injection
Iron sucrose injection is an iron replacement product indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.
Viatris, Amphastar Pharmaceuticals Get FDA Approvals of Iron Sucrose Products
Venofer was approved in the U.S. in 2000. It was developed by Vifor Pharma, which is now part of CSL Ltd. American Regent, a unit of Daiichi Sankyo, manufactures and sells it in the U.S. under a license agreement.
Amphastar Pharma’s iron sucrose injection receives US FDA approval to treat iron deficiency anaemia in patients with CKD
Amphastar Pharma’s iron sucrose injection receives US FDA approval to treat iron deficiency anaemia in patients with CKD: Rancho Cucamonga, California Tuesday, August 12, 2025,
Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
According to the FDA, Amphastar's iron sucrose injection meets the criteria for bioequivalence and therapeutic equivalence to Venofer ®for the treatment of iron deficiency anemia in patients with chronic kidney disease RANCHO CUCAMONGA,
Amphastar gets FDA nod for generic iron sucrose injection
Amphastar Pharmaceuticals (NASDAQ:AMPH) said that the FDA approved its generic iron sucrose injection, USP 50mg/2.5mL, 100mg/5mL, and 200mg/10mL, to treat anemia in patients with chronic kidney disease.
Amphastar Shares Rise Following FDA Approval of Generic Iron Sucrose Injection
Amphastar Pharmaceuticals (NASDAQ:AMPH) saw its stock increase by 4% after the company announced that the FDA had approved its generic version of iron sucrose injection, a treatment used for iron deficiency anemia in patients with chronic kidney disease.
The Pharma Letter9h

Viatris first to win US approval for generic Venofer

US generics major Viatris has won US Food and Drug Administration (FDA) approval for iron sucrose injection, USP, an ...
CNBCTV1821h

Dr. Reddy's, Aurobindo face a near-'lost' opportunity for an important pipeline drug; Here's why

Among Indian generics makers, Iron Sucrose had been considered a key pipeline product for Dr. Reddy’s Laboratories and ...
Healthline7y

Sucrose vs. Glucose vs. Fructose: What’s the Difference?

Sucrose, glucose, and fructose are three types of sugar that contain the same number of calories gram for gram. They’re all found naturally in fruits, vegetables, dairy products, and grains but ...
ucdavis.edu3y

Both Sucrose and High Fructose Corn Syrup Linked to ... - UC Davis

Consuming sucrose, the more “natural form of sugar,” may be as bad for your health as consuming high fructose corn syrup, according to a University of California, Davis, study published in the ...